Answers are grounded in this paper and cite their sources.
Demonstrates enhanced vaccine efficacy via synergistic cellular and humoral immunity in pigs, implying improved protection.
T cell responses and neutralizing antibody titers at 28 days post-vaccination compared to the inactivated vaccine alone, implying that synergistic cellular and humoral immunity may contribute to enhanced protective efficacy. This study identified promising candidate components for developing efficacious SVA vaccines, while the identified conserved T cell epitopes provided a critical foundation for designing broad-spectrum multi-epitope vaccines.
No takes yet. Share an insight, caveat, or question.
Mu et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: